-
1دورية أكاديمية
المؤلفون: Rand A. Alattar, Shiema Abdalla, Tasneem Abdallah, Rashid Kazman, Aseelah Qadmour, Tawheeda Ibrahim, Bassem Alhariri, Shahd H. Shaar, Abeer Bajwa, Abeir Alimam, Rabia Qazi, Fatma Ben Abid, Joanne Daghfal, Ali Eldeeb, Kinda Shukri, Ahmed Elsayed, Fatima Rustom, Musaed Alsamawi, Alaaeldin Abdelmajid, Miguel A.P. Basulto, Armando A.R. Cobian, Mohamed Abukhattab, Abdullatif Alkhal, Muna A. Almaslamani, Ali S. Omrani
المصدر: Journal of Infection and Public Health, Vol 15, Iss 10, Pp 1061-1064 (2022)
مصطلحات موضوعية: COVID-19, SARS-CoV-2, Pneumonia, Favipiravir, Antiviral therapy, Infectious and parasitic diseases, RC109-216, Public aspects of medicine, RA1-1270
وصف الملف: electronic resource
-
2
المؤلفون: Fatima Rustom, Rand A. Alattar, Ali M. Eldeeb, Rashid Kazman, Shiema Abdalla, Fatma Ben Abid, Abeir Bh Alimam, Shahd H. Shaar, Ali S. Omrani, Musaed Alsamawi, Aseelah Qadmour, Tasneem A.K. Abdallah, Miguel A. Paulino Basulto, Joanne Daghfal, Alaaeldin Abdelmajid, Abeer Bajwa, Kinda Shukri, Mohamed Abukhattab, Bassem Alhariri, Armando Ar Cobian, Rabia Qazi, Tawheeda B. H. Ibrahim, Muna Almaslamani, Ahmed Elsayed, Abdullatif Al-Khal
مصطلحات موضوعية: medicine.medical_specialty, Proportional hazards model, business.industry, Internal medicine, Hazard ratio, Cohort, Propensity score matching, Clinical endpoint, medicine, Favipiravir, business, Adverse effect, Confidence interval
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b5f42e2b27b5b559c0e3385482964d02
https://doi.org/10.1101/2021.11.29.21267042 -
3
المؤلفون: Shiema Abdalla, Shahd H. Shaar, Muna Almaslamani, Mohamed Abukhattab, Tawheeda B. H. Ibrahim, Mohamed Aboukamar, Joanne Daghfal, Hussam Alsoub, Ali S. Omrani, Mohamed Y. Khatib, Kinda Shukri, Rand A. Alattar
المصدر: Journal of Medical Virology
مصطلحات موضوعية: Male, medicine.medical_specialty, coronavirus, Antibodies, Monoclonal, Humanized, Antiviral Agents, SARS‐CoV‐2, law.invention, 03 medical and health sciences, chemistry.chemical_compound, tocilizumab, 0302 clinical medicine, Tocilizumab, Randomized controlled trial, Interquartile range, law, COVID‐19, Internal medicine, Diabetes mellitus, Virology, medicine, Humans, 030212 general & internal medicine, Adverse effect, Qatar, Research Articles, Retrospective Studies, business.industry, IL‐6, Middle Aged, medicine.disease, Intensive care unit, Respiration, Artificial, COVID-19 Drug Treatment, Infectious Diseases, C-Reactive Protein, chemistry, Concomitant, 030211 gastroenterology & hepatology, Female, business, Kidney disease, Research Article